Advanced search
Publication Cover
Personalized Medicine Volume 3, 2006 - Issue 2
Submit an article Journal homepage
111
Views
0
CrossRef citations to date
0
Altmetric
Technology Report

Nucleic Acid Quantification and Disease Outcome Prediction in Colorectal Cancer

Stephen A Bustina University of London, Institute of Cell and Molecular Science Barts and the London Queen Mary‘s School of Medicine and Dentistry, London, UK;* Centre for Academic Surgery, 3rd Floor Alexandra Wing, The Royal London Hospital, LondonE1 1BB, UK. Tel.: +44 020 7377 7000 Ext. 2431; [email protected]
Pages 207-216 | Published online: 05 May 2006

Bibliography

  • Boyle P , FerlayJ: Cancer incidence and mortality in Europe, 2004.Ann Oncol.16, 481–488 (2005).
  • Jemal A , MurrayT, WardE et al.: Cancer statistics, 2005. CA Cancer J. Clin.55, 10–30 (2005).
  • Hermanek P : pTNM and residual tumor classifications: problems of assessment and prognostic significance.World J. Surg.19, 184–190 (1995).
  • Ahmed FE : Artificial neural networks for diagnosis and survival prediction in colon cancer.Mol. Cancer4, 29 (2005).
  • Ahmed FE : Molecular markers that predict response to colon cancer therapy.Expert Rev. Mol. Diagn.5, 353–375 (2005).
  • Ahmed FE : Development of novel diagnostic and prognostic molecular markers for sporadic colon cancer.Expert Rev. Mol. Diagn.5, 337–352 (2005).
  • Bustin SA , DorudiS: Molecular assessment of tumor stage and disease recurrence using PCR-based assays.Mol. Med. Today4, 389–396 (1998).
  • Ramaswamy S , RossKN, LanderES, Golub TR:A molecular signature of metastasis in primary solid tumors. Nature Genet.33, 49–54 (2003).
  • Ribic CM , SargentDJ, MooreMJ et al.: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med.349, 247–257 (2003).
  • Hawkins NJ , TomlinsonI, MeagherA, WardRL: Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer.Br. J. Cancer84, 232–236 (2001).
  • Wang Y , JatkoeT, ZhangY et al.: Gene expression profiles and molecular markers to predict recurrence of Dukes’ B colon cancer. J. Clin. Oncol.22, 1564–1571 (2004).
  • Bustin SA , MuellerR: Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis.Clin. Sci. (Lond.)109, 365–379 (2005).
  • Bustin SA , MuellerR: Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer.Mol. Aspects Med.27, 192–223 (2006).
  • Hayashi N , ItoI, YanagisawaA et al.: Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet345, 1257–1259 (1995).
  • Clarke GA , RyanE, CroweJP, O’KeaneJC, MacMathunaP: Tumor-derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer-related death.Int. J. Colorectal Dis.16, 108–111 (2001).
  • Anker P , LefortF, VasioukhinV et al.: K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology112, 1114–1120 (1997).
  • Lecomte T , BergerA, ZinzindohoueF et al.: Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer100, 542–548 (2002).
  • Ng EK , TsuiNB, LamNY et al.: Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem.48, 1212–1217 (2002).
  • Bustin SA , GyselmanVG, WilliamsNS, DorudiS: Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients.Br. J. Cancer79, 1813–1820 (1999).
  • Wyld DK , SelbyP, PerrenTJ et al.: Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int. J. Cancer79, 288–293 (1998).
  • Champelovier P , MongelardF, Seigneurin D: CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res.19, 2073–2078 (1999).
  • Wharton RQ , JonasSK, GloverC et al.: Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin. Cancer Res.5, 4158–4163 (1999).
  • Bustin SA , GyselmanVG, SiddiqiS, Dorudi S: Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.Int. J. Surg. Invest.2, 49–57 (2000).
  • Bustin SA , SiddiqiS, AhmedS, HandsR, DorudiS: Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.Int. J. Cancer108, 412–417 (2004).
  • Oberg AN , LindmarkGE, IsraelssonAC, HammarstromSG, HammarstromML: Detection of occult tumor cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAs.Int. J. Cancer111, 101–110 (2004).
  • Keilholz U , WillhauckM, RimoldiD et al.: Reliability of reverse transcription-polymerase chain reaction (RT-PCR)- based assays for the detection of circulating tumor cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group. Eur. J. Cancer34, 750–753 (1998).
  • Lacroix J , DoeberitzMK: Technical aspects of minimal residual disease detection in carcinoma patients.Semin. Surg. Oncol.20, 252–264 (2001).
  • Heid CA , StevensJ, LivakKJ, WilliamsPM: Real time quantitative PCR.Genome Res.6, 986–994 (1996).
  • Bustin SA : Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.J. Mol. Endocrinol.25, 169–193 (2000).
  • Bustin SA , NolanT: Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction.J. Biomol. Tech.15, 155–166 (2004).
  • Bustin SA : Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.J. Mol. Endocrinol.29, 23–39 (2002).
  • Muller MC , HordtT, PaschkaP et al.: Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia. Acta Haematol.112, 30–33 (2004).
  • Bustin SA : A-Z of quantitative PCR. IUL Press, La Jolla, CA, USA (2004).
  • Afzal MA , OsterhausAD, CosbySL et al.: Comparative evaluation of measles virus-specific RT-PCR methods through an international collaborative study. J. Med. Virol.70, 171–176 (2003).
  • Niesters HG : Quantitation of viral load using real-time amplification techniques.Methods25, 419–429 (2001).
  • Gabert J , BeillardE, van der Velden VH et al.: Standardization and quality control studies of ’real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – a Europe Against Cancer program. Leukemia17, 2318–2357 (2003).
  • Niesters HG : Molecular and diagnostic clinical virology in real time.Clin. Microbiol. Infect.10, 5–11 (2004).
  • Bustin SA : Real-time, fluorescence-based quantitative PCR: a snapshot of current procedures and preferences.Expert Rev. Mol. Diagn.5, 493–498 (2005).
  • Ladanyi A , SoongR, TabitiK, MolnarB, TulassayZ: Quantitative reverse transcription-PCR comparison of tumor cell enrichment methods.Clin. Chem.47, 1860–1863 (2001).
  • Vlems F , SoongR, DiepstraH et al.: Effect of blood sample handling and reverse transcriptase-polymerase chain reaction assay sensitivity on detection of CK20 expression in healthy donor blood. Diagn. Mol. Pathol.11, 90–97 (2002).
  • Max N , WillhauckM, WolfK et al.: Reliability of PCR-based detection of occult tumor cells: lessons from real-time RT-PCR. Melanoma Res.11, 371–378 (2001).
  • Zippelius A , LutterbuseR, RiethmullerG, PantelK: Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells.Clin. Cancer Res.6, 2741–2750 (2000).
  • Vlems FA , DiepstraJH, CornelissenIM et al.: Limitations of cytokeratin 20 RT-PCR to detect disseminated tumor cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumor tissue. Mol. Pathol.55, 156–163 (2002).
  • Raggi CC , VerderioP, PazzagliM et al.: An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man probes. Clin. Chem. Lab. Med.43, 542–548 (2005).
  • Willey JC , CrawfordEL, JacksonCM et al.: Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am. J. Respir. Cell Mol. Biol.19, 6–17 (1998).
  • Crawford EL , WarnerKA, KhuderSA, ZahorchakRJ, WilleyJC: Multiplex standardized RT-PCR for expression analysis of many genes in small samples.Biochem. Biophys. Res. Commun.293, 509–516 (2002).
  • Willey JC , CrawfordEL, KnightCR et al.: Standardized RT-PCR and the standardized expression measurement center. Methods Mol. Biol.258, 13–41 (2004).
  • Willey JC , KnightCR, CrawfordEL et al.: Use of standardized reverse transcription-polymerase chain reaction and the standardized expression measurement center in multi-institutional trials to develop meaningful lung cancer classification based on molecular genetic criteria. Chest125, 155S–156S (2004).
  • Pagliarulo V , GeorgeB, BeilSJ et al.: Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR. Mol. Cancer3, 5 (2004).
  • Sanchez JA , PierceKE, RiceJE, WanghLJ: Linear-after-the-exponential (LATE)-PCR: an advanced method of asymmetric PCR and its uses in quantitative real-time analysis.Proc. Natl Acad. Sci. USA101, 1933–1938 (2004).
  • Hartshorn C , AnshelevichA, WanghLJ: Rapid, single-tube method for quantitative preparation and analysis of RNA and DNA in samples as small as one cell.BMC Biotechnol.5, 2 (2005).
  • Zetter BR : The cellular basis of site-specific tumor metastasis.N. Engl. J. Med.322, 605–612 (1990).
  • Ramaswamy S , GolubTR: DNA microarrays in clinical oncology.J. Clin. Oncol.20, 1932–1941 (2002).
  • Shih W , ChettyR, TsaoMS: Expression profiling by microarrays in colorectal cancer.Oncol. Rep.13, 517–524 (2005).
  • Alon U , BarkaiN, NottermanDA et al.: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl Acad. Sci. USA96, 6745–6750 (1999).
  • Notterman DA , AlonU, SierkAJ, Levine AJ: Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res.61, 3124–3130 (2001).
  • Lin YM , FurukawaY, TsunodaT et al.: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene21, 4120–4128 (2002).
  • Hegde P , QiR, GaspardR et al.: Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res.61, 7792–7797 (2001).
  • Kwon HC , KimSH, RohMS et al.: Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum47, 141–152 (2004).
  • Yanagawa R , FurukawaY, TsunodaT et al.: Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia3, 395–401 (2001).
  • Bertucci F , SalasS, EysteriesS et al.: Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene23, 1377–1391 (2004).
  • Eschrich S , YangI, BloomG et al.: Molecular staging for survival prediction of colorectal cancer patients. J. Clin. Oncol.23, 3526–3535 (2005).
  • Arango D , LaihoP, KokkoA et al.: Gene-expression profiling predicts recurrence in Dukes’ C colorectal cancer. Gastroenterology129, 874–884 (2005).
  • Bustin SA , DorudiS: The value of microarray techniques for quantitative gene profiling in molecular diagnostics.Trends Mol. Med.8, 269–272 (2002).
  • Hoos A , NissanA, StojadinovicA et al.: Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. Clin Cancer Res.8, 3841–3849 (2002).
  • Choi JK , ChoiJY, KimDG et al.: Integrative analysis of multiple gene expression profiles applied to liver cancer study. FEBS Lett.565, 93–100 (2004).
  • Hosack DA , DennisG Jr, Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol.4, R70 (2003).
  • Choi JK , YuU, YooOJ, KimS: Differential coexpression analysis using microarray data and its application to human cancer.Bioinformatics21, 4348–4355 (2005).
  • Hunter K : Host genetics influence tumor metastasis.Nature Rev. Cancer6, 141–146 (2006).
  • Boedefeld WM 2nd, Bland KI, Heslin MJ: Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma. Ann. Surg. Oncol.10, 839–851 (2003).
  • Al-Mulla F , KeithWN, PickfordIR, Going JJ, Birnie GD: Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer24, 306–314 (1999).
  • Baisse B , BouzoureneH, SaragaEP, BosmanFT, BenhattarJ: Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.Int. J. Cancer93, 346–352 (2001).
  • Losi L , BaisseB, BouzoureneH, Benhattar J: Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis26, 916–922 (2005).
  • Kitahara O , FurukawaY, TanakaT et al.: Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res.61, 3544–3549 (2001).
  • Hendrix MJ , SeftorEA, MeltzerPS et al.: Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc. Natl Acad. Sci. USA98, 8018–8023 (2001).
  • Koukourakis MI , GiatromanolakiA, Harris AL, Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res.66, 632–637 (2006).
  • Joyce JA : Therapeutic targeting of the tumor microenvironment.Cancer Cell7, 513–520 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.